Role of lymphadenectomy in the treatment of clinical stage I non-small cell lung cancer.
It has been proved with acceptable certainty that MLND does not increase complications in lung cancer surgery and improves the accuracy of staging. This applies to lung cancer at all resectable stages. As far as survival is concerned, statistically significant differences have been suggested by some authors and are more evident for early stages. Stage I NSCLC, a local disease, may profit from lymph node dissection, a procedure that can effectively control local tumor, reduce local recurrence, and improve long-term survival.
De Giacomo
Tiziano
T
University of Rome La Sapienza, Division of Thoracic Surgery, Policlinico Umberto I, Dipartimento Paride Stefanini, Via le del Policlinico 155, 00161 Rome, Italy.
Venuta
Federico
F
Rendina
Erino Angelo
EA
D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008197:Lymph Node Excision; D008482:Mediastinum; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging